Wednesday, June 3, 2020
The Hemp CBD Times. Every minute hemp cbd industry news.


FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

PRESS RELEASE TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced…

By hempcbdtimes , in Coronavirus COVID-19 FSD Pharma Inc. Hemp Policy & Legal Investigational New Drug Application (IND) Press Releases Science and Technology U.S. Food and Drug Administration (FDA) Uncategorized , at June 3, 2020

Next Page »